• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCabaletta Bio
    Picture of Cabaletta Bio logo

    CABA — Cabaletta Bio News Story

    $3.040.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $495.69m
    • Enterprise Value
      $403.02m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CABA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CABA Dividends
    All News

    NASDAQ RESUMED AT 09:42 AM

    Picture of Cabaletta Bio logoCabaletta Bio
    14/12/2021 14:43
    NASDAQ RESUMED  CABA.O  AT 09:42 AM
    

    Recent news on Cabaletta Bio

    See all news
    • Cabaletta Bio Q1 net loss widens as R&D costs rise

      14/05/2026 12:14
    • Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform

      14/04/2026 21:32
    • Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms

      12/01/2026 12:40
    • Cabaletta Bio reports smaller-than-expected Q3 loss

      10/11/2025 12:42
    • U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity

      10/10/2025 08:16

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.